Cargando…
Low oral dose of 4-methylumbelliferone reduces glial scar but is insufficient to induce functional recovery after spinal cord injury
Spinal cord injury (SCI) induces the upregulation of chondroitin sulfate proteoglycans (CSPGs) at the glial scar and inhibits neuroregeneration. Under normal physiological condition, CSPGs interact with hyaluronan (HA) and other extracellular matrix on the neuronal surface forming a macromolecular s...
Autores principales: | Štepánková, Kateřina, Chudíčková, Milada, Šimková, Zuzana, Martinez-Varea, Noelia, Kubinová, Šárka, Urdzíková, Lucia Machová, Jendelová, Pavla, Kwok, Jessica C. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628150/ https://www.ncbi.nlm.nih.gov/pubmed/37932336 http://dx.doi.org/10.1038/s41598-023-46539-5 |
Ejemplares similares
-
The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury
por: Chudickova, Milada, et al.
Publicado: (2019) -
Planet of the AAVs: The Spinal Cord Injury Episode
por: Stepankova, Katerina, et al.
Publicado: (2021) -
New Model of Ventral Spinal Cord Lesion Induced by Balloon Compression in Rats
por: Krupa, Petr, et al.
Publicado: (2020) -
4-Methylumbeliferone Treatment at a Dose of 1.2 g/kg/Day Is Safe for Long-Term Usage in Rats
por: Štěpánková, Kateřina, et al.
Publicado: (2023) -
The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application
por: Krupa, Petr, et al.
Publicado: (2018)